Intelligence · Clinical Pipeline
Metabolic & obesity R&D Pipeline
GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
- Programs
- 755
Quick answer
Metabolic & obesity: NovaPharmaNews indexes 755 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Top sponsors
- Takeda 75 programs
- NovoThirteen 61 programs
- First People's Hospital 38 programs
- Regeneron UK 35 programs
- Eli Lilly and 29 programs
- Chinese Academy of 26 programs
- United Therapeutics Europe 24 programs
- Boehringer Ingelheim 23 programs
- Anaxis Pharma 20 programs
- HOFFMANN-LA ROCHE 17 programs
- LEXICON PHARMACEUTICALS 16 programs
- George Institute for 15 programs
-
GIP/GLP-1a
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
GK1-399 (formerly TTP399)
vTv Therapeutics
Type 2 Diabetes Mellitus
1 trial -
GL0034 4 mg/ml, 1 ml per vial, GL0034 3 mg/ml, 1 ml per vial, Same solution as for GL0034 without drug substance; solution for subcutaneous injection; volume identical to dose of test product, GL0034 1mg/ml, 0.6ml per vial, GL0034 1 mg/ml, 1 ml per vial
Lacuna Pharma Pty Ltd
Type 2 diabetes mellitus
1 trial -
GSBR-1290
Structure Therapeutics
Overweight or Obesity
1 trial -
GSK2330672
ELITE PHARMACEUTICALS INC /NV/
Diabetes Mellitus, Type 2
1 trial -
GWP42004
Jazz Pharmaceuticals Ireland Limited
Diabetes Mellitus, Type 2
1 trial -
GZR102
Gan & Lee Pharmaceuticals.
Type 2 Diabetes Mellitus (T2DM)
1 trial -
Grafalon 20 mg/ml koncentrát pro infuzní roztok
The George Institute
Type 1 diabetes
1 trial -
High Dose SAB-142
SAB Biotherapeutics
Type 1 Diabetes
1 trial -
Humalog
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type 2
1 trial -
Humalog
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
ILT-101 liquide, Placebo of ILT-101, CICLOSPORIN
Pari Pharma GmbH
Patient with newly diagnosed (≤ 3 months) type 1 diabetes stage 3
1 trial -
IOHEXOL , Placebo to match LY3437943, Retatrutide
Eli Lilly Co.
Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
1 trial -
ISIS 113715
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
5 trials -
ISIS-APOCIIIRX
IONIS PHARMACEUTICALS INC
Type 2 Diabetes
1 trial -
ISIS-FGFR4RX
IONIS PHARMACEUTICALS INC
Obesity
1 trial -
ISIS-GCCRRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
ISIS-GCGRRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes
1 trial -
ISIS-GCGRRx - Dose Level 1
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
ISIS-GCGRRx- Dose Level 1
IONIS PHARMACEUTICALS INC
Type 2 Diabetes
1 trial -
ISIS-PTP1BRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
IW-1973
Akebia Europe Limited
Type 2 Diabetes Mellitus With Diabetic Nephropathy
1 trial -
IW-1973
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
IW-9179
IRONWOOD PHARMACEUTICALS INC
Diabetic Gastroparesis
1 trial -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type 1
2 trials -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type II
1 trial -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
Investigational new drug company code: BGS649
Mereo BioPharma Group plc
Obese Hypogonadotropic Hypogonadism
1 trial -
Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy
Eledon Pharmaceuticals
Type 1 Diabetes Mellitus
1 trial -
JMKX000623
Jemincare
Diabetic Peripheral Neuropathic Pain
1 trial -
Jiangtang Tiaozhi recipe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type2 Diabetes
1 trial -
KAI-7535
Kailera Therapeutics
Obesity
2 trials -
KVD001 Injection
Kalvista Pharmaceuticals (Ireland) Limited
Diabetic Macular Edema
2 trials -
Kerendia 10 mg film coated tablets, Kerendia 20 mg film-coated tablets, Finerenone/Kerendia 10mg and 20mg Placebo equal to test product except active substance, Empagliflozin/Jardiance 10mg Placebo equal to test product except active substance, Jardiance 10 mg film-coated tablets
Bayer AG
Chronic kidney disease in type 2 diabetes mellitus
1 trial -
LB54640
Rhythm Pharmaceuticals Netherlands B.V.
Hypothalamic Obesity
1 trial -
LGD-6972-5 mg
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
LIK066
Novartis Pharmaceuticals
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
1 trial -
LX4211 Low Dose
LEXICON PHARMACEUTICALS, INC.
Type 2 Diabetes Mellitus
1 trial -
LX9211
LEXICON PHARMACEUTICALS, INC.
Diabetic Peripheral Neuropathy
1 trial -
Ladarixin, Placebo to match Ladarixin
Dompe' Farmaceutici S.p.A.
Recent onset Type 1 Diabetes
1 trial -
MB07803
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
MLN1202 Placebo
Takeda
Diabetic Nephropathy
1 trial -
MSC
Shandong University
Type 2 Diabetes
1 trial -
MSC and PRP
Hospital Authority, Hong Kong
Type 1 Diabetes Mellitus
1 trial -
Matching Placebo
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
MenSCs transplantation
The First People's Hospital of Lianyungang
Type 1 Diabetes Mellitus
1 trial -
Miricorilant
CORCEPT THERAPEUTICS INC
Nonalcoholic Steatohepatitis (NASH)
3 trials -
Miricorilant (Cohort A)
CORCEPT THERAPEUTICS INC
Nonalcoholic Steatohepatitis (NASH)
1 trial
Frequently asked questions
How many metabolic & obesity pipeline programs are tracked?
755 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs